Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biomedicine
NIH Funds New Wellstone Research Center for Muscular Dystrophy at Boston Biomedical Research Institute
September 27th, 2008
The U.S. National Institutes of Health (NIH) have awarded $9 million to launch a unique collaboration of researchers, clinicians, patients, government research agencies and pharmaceutical/biomedical companies to study the causes and potential treatments for facioscapulohumeral muscular dystrophy (FSHD), a muscle weakening and disabling disease that affects, at the least, one in 20,000 individuals worldwide. The award will create the first Senator Wellstone Muscular Dystrophy Cooperative Research Center (MD CRC) to focus on FSHD, the award recipients announced. Headquartered at the Boston Biomedical Research Institute (BBRI), this center for excellence in muscular...
Source: Law & Health Weekly (2008-09-27)
|
